| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
2 companies
Hassard James is a Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $9.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 15,000 | $44.08 | $661,200.00 | -33.9% | +20.4% | -33.7% | |
| Jun 21, 2024 | CRNX Crinetics Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 15,000 | $44.66 | $669,900.00 | -33.9% | +18.2% | -33.8% | |
| Jun 22, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 3,625 | $89.22 | $323,422.50 | -3.3% | -29.8% | -64.5% | |
| Jan 7, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 15,625 | $75.00 | $1,171,875.00 | -12.5% | - | - |